Tax rise mitigates Japan price cut but DPP-4s hit hard
This article was originally published in Scrip
Executive Summary
The next regular biennial revision of drug reimbursement prices in Japan will see levels cut by an average of 2.65% across the board on 1 April, including the mitigating effect of an increase in the general consumption tax at the same time.